Market-moving stories, structured for trading automations. Plug into Claude Desktop, Cursor, or your own agent in minutes.
Crawled and deduplicated across the open web. The strongest candidates get a full AI pass with a 1–10 relevance score and per-ticker analysis.
Distinct publisher domains scanned in the last 30 days.
Only the best clear the relevance floor with a verified ticker. The rest is filtered out.
Median from EDGAR publication to an enriched, ticker-tagged row, covering insider trades (Form 4), corporate actions (8-K) and foreign issuers' earnings releases (6-K).
All of it can come to you. News alerts land in Telegram, email, or a webhook the moment a story clears your filters, and the tickers, categories, and relevance threshold are yours to set.
"Claude, what moved NVDA today?"
alphai_news_search → MCP
Try it"Send only high-relevance earnings news for my watchlist."
/api/news/?category=earnings · min_relevance=7
Try it"Build a Telegram bot for market-moving news in 10 minutes."
/api/news/trending/ + your bot framework
Try it"Any insider buying in my watchlist this week?"
alphai_insider_news → MCP · /api/news/insider/
Try it"Feed my agent relevance-scored financial news via MCP."
OAuth 2.1 · News & watchlist tools · Streamable HTTP
Try itIonQ announced a definitive agreement to buy Elisity in an all‑stock transaction valued at up to $1.3 billion, with up to $150 million of performance‑based earnouts. The exchange ratio is set by a reference share‑price range of $33.07 to $49.61 per IonQ share. The deal is expected to close in the fourth quarter of 2026, subject to customary closing conditions and regulatory approval.
Equinor announced that it will sell a 30% non‑operated stake in the Bay du Nord development to Shell Canada Energy, while keeping a 70% share and remaining the operator. The transaction, announced on 9 Oct 2026, does not disclose a purchase price. The partners said the deal moves the project toward a final investment decision expected in early 2027, with production targeted for around 2031.
STERIS agreed on October 12, 2026, to acquire Pennsylvania-based surgical products maker Xodus Medical for $2.1 billion. Xodus is projected to contribute 2026 revenue of $245 million and adjusted EBIT of $135 million. The transaction is expected to close by December 31, 2026, subject to approvals, and will be financed mainly with debt.
Viatris announced a definitive agreement to acquire all outstanding shares of Pacira BioSciences for $36.50 in cash per share, valuing the target at $1.65 billion. The transaction adds Pacira’s two U.S. non‑opioid pain products, EXPAREL and ZILRETTA, to Viatris’ portfolio and is slated to close by the end of 2026, subject to customary conditions. Viatris said the purchase will be immediately accretive to its guidance and will be funded mainly with cash and a modest amount of short‑term borrowing. Pacira will become a wholly‑owned subsidiary and its Nasdaq listing will be terminated.
Gran Tierra Energy Inc. held a special meeting on Oct. 9, 2026 where stockholders voted to sell its Colombian and Ecuadorian operations to Maurel & Prom. The transaction is valued at about US$1.33 billion and is expected to close around Dec. 31, 2026, subject to regulatory approvals. The company anticipates receiving roughly US$315 million in net cash, with US$250 million paid at closing and US$65 million a year later.
KKR & Co. Inc. (KKR) agreed to acquire Gen II Fund Services for $5.1 billion, including debt, from Hg, General Atlantic, and other investors. Gen II provides services to private-market managers, serving over 275 firms with $2 trillion in capital. The acquisition aims to expand KKR's private equity portfolio and is expected to close in 2027. KKR plans to invest in Gen II's technology and AI solutions, but the deal's financial returns and costs remain uncertain.
RPC, Inc. (RES) will release its Q3 2026 financial results on October 29, 2026, before market open. A conference call will follow at 9:00 a.m. ET. The company provides oilfield services and equipment to oil and gas companies in the U.S. and international markets.
Semtech (SMTC) shares fell 10% to $168.28 on Monday, extending a four-day losing streak from a 52-week high of $201.99, amid a broader tech sector pullback.
Aurora Cannabis (ACB) stock rose 25% after Curaleaf (CURLF) raised its takeover offer to $5, a mix of cash and stock. Aurora's board is reviewing the offer, which expires Dec. 4. Aurora is unprofitable but has international expansion plans. Curaleaf's interest may drive further bids, but rejection could cause the stock to fall.
CME Group has completed initial cloud performance testing for CME Globex, achieving faster trading times. The Aurora Cloud Region and co-location facility are ahead of schedule, with client testing expected in mid-2027. Livestock market migration to the cloud is planned for late 2027. According to CEO Terry Duffy, the company is progressing faster than anticipated.
CME Group and Google Cloud will launch a new trading platform at CME's Aurora site, with client testing expected in mid-2027. The platform aims to reduce trading latency and will support CME Group markets. CME Group's CEO Terry Duffy expressed satisfaction with the accelerated timeline. The Aurora Cloud Region is ahead of schedule, and the livestock market migration to the cloud is planned for late 2027, eliminating the need for interim relocation to Dallas.
The same scored news feed that powers AlphAI is available as a REST API, and as an MCP server for Claude Desktop, Cursor, and any other agent host. Articles arrive enriched and linked to tickers in real time.
Dropping it into an existing stack? The Python and n8n quick starts are copy-paste.
curl https://api.alphai.io/api/news/ \
-H "Authorization: Bearer ${ALPHAI_API_KEY}" \
-G -d "symbol=NVDA"
# → {
# "results": [{
# "original": {
# "title": "Nvidia export curbs tighten...",
# "summary": "The White House is expected to...",
# "time_published": "2026-04-18T14:32:00Z"
# },
# "enrichment": {
# "category": "macro",
# "tickers": ["NVDA"],
# "relevance_score": 9
# }
# }, ...],
# "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.
Subscribe now and keep this rate for as long as you stay subscribed. We will not raise it for you.
Don’t want to watch the feed? Follow a ticker and we’ll deliver a daily digest of everything that clears your relevance bar, so you don’t have to check back.
Set up alerts